Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0000950170-24-012832

EVP, CFO & Treasurer sold 4,205 shares at $1.59 ($6,671)

From the SEC's structured data for this filing

Trades in this filing

Mason Michael · EVP, CFO & Treasurer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-02-06 Sale : show line 1 in the form −4,205 $1.59 $6,671 246,945 D
Open-market sales · 4,205 sh · avg $1.59 · $6,671
Loading xslF345X05/ownership.xml…